1 / 26

Michigan Colorectal Cancer Data

Colorectal cancer Priority. By 2010, increase to 75 percent the proportion of average-risk people in Michigan who report having received appropriate colorectal cancer screening and follow-up of abnormal screening results. 3. CRCAC 6.21.06. Objectives. 1: Increase the proportion of health care providers that recommend appropriate colorectal cancer screening2: Assess status of health care provider training regarding appropriate colorectal cancer screening procedures3: Continue to increase health20

oshin
Download Presentation

Michigan Colorectal Cancer Data

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    1. Michigan Colorectal Cancer Data May Yassine, PhD Michigan Public Health Institute

    2. Colorectal cancer Priority By 2010, increase to 75 percent the proportion of average-risk people in Michigan who report having received appropriate colorectal cancer screening and follow-up of abnormal screening results

    3. 3 CRCAC 6.21.06 Objectives 1: Increase the proportion of health care providers that recommend appropriate colorectal cancer screening 2: Assess status of health care provider training regarding appropriate colorectal cancer screening procedures 3: Continue to increase health plan commitment to colorectal cancer screening 4: Increase awareness of colorectal cancer risks, prevention and testing for early detection

    4. 4 CRCAC 6.21.06 Available Measures Screening Rates Abnormal Follow-up Knowledge of risk factors HEDIS screening rates Incidence/Mortality rates Time Trends Stage at diagnosis Geographical Distribution

    5. Colorectal Cancer Incidence and Mortality

    6. 6 CRCAC 6.21.06 Colorectal Cancer Mortality Rates: MI vs. U.S. 2002

    7. 7 CRCAC 6.21.06 Michigan Mortality Ranking 2002 Highest Mortality Rate 24.5/100,000 (District of Columbia) Michigan Mortality Rate 19.2/100,000 Ranked 19th among states Lowest Mortality Rate 15.3/100,000 (Utah)

    8. 8 CRCAC 6.21.06 Colorectal Cancer Mortality Rates by County, 1994-2003

    9. 9 CRCAC 6.21.06 Colorectal Cancer Mortality Rates by Race, 1989-2002

    10. 10 CRCAC 6.21.06 Estimated Annual Percent Change in Mortality Rates for Colorectal Cancer in Michigan vs. U.S., 1993-2002

    11. 11 CRCAC 6.21.06 Colorectal Cancer Incidence Rates: MI vs. U.S. 2001

    12. 12 CRCAC 6.21.06 Michigan Incidence Ranking 2002 Highest Incidence Rate 61.6/100,000 (Pennsylvania) Michigan Incidence Rate* 52.8/100,000 Ranked 21st among states** Lowest Incidence Rate 40.7/100,000 (New Mexico)

    13. Stage at Diagnosis

    14. 14 CRCAC 6.21.06 Invasive Colorectal Cancer by Stage at Diagnosis and Race, Michigan 2002

    15. 15 CRCAC 6.21.06 Percentage of Colorectal Cancer Cases Localized at Diagnosis by County

    16. 16 CRCAC 6.21.06 Percentage of Colorectal Cancer Cases Localized at Diagnosis by County

    17. Screening Rates for Colorectal Cancer

    18. 18 CRCAC 6.21.06 Men and Women Age 50+ Who Had Any Appropriately Timed* Colorectal Cancer Screening by Population Group, SCBRFS 2004 The MCC recommendation for colorectal cancer screening is to have either an annual fecal occult blood test (FOBT) or a sigmoidoscopy every five years or a yearly FOBT with a sigmoidoscopy every five years or to have a colonoscopy every ten years or a double contrast barium enema (DCBE) every five years The MCC recommendation for colorectal cancer screening is to have either an annual fecal occult blood test (FOBT) or a sigmoidoscopy every five years or a yearly FOBT with a sigmoidoscopy every five years or to have a colonoscopy every ten years or a double contrast barium enema (DCBE) every five years

    19. 19 CRCAC 6.21.06 Men and Women Age 50+ Who Had Any Appropriately Timed* Colorectal Cancer Screening by Gender and Population Group, SCBRFS 2004

    20. 20 CRCAC 6.21.06 Men and Women Age 50+ Who Had Any Appropriately Timed* Colorectal Cancer Screening SCBRFS 2001-02 vs. 2004

    21. 21 CRCAC 6.21.06 Men and Women Age 50+ Who Had Any Appropriately Timed* Colorectal Cancer Screening by Gender, SCBRFS 2001-02 vs. 2004

    22. 22 CRCAC 6.21.06 Utilization of Colorectal Cancer Screening Tests Among Men and Women Age 50+ Years General Population, SCBRFS 2004

    23. 23 CRCAC 6.21.06 HEDIS Colorectal Cancer Screening Rates, 2005*

    24. 24 CRCAC 6.21.06 Knowledge of Risk Factors Among Men and Women Age 50+ in Michigan, SCBRFS 2004

    25. 25 CRCAC 6.21.06 Michigan Men and Women Age 50+ Who Had an Abnormal Test Result in the Past 10 Years by Population Group, SCBRFS 2004

    26. 26 CRCAC 6.21.06 Future Data Sources Knowledge, Attitudes and Practices (KAP) Primary Care Provider Survey CRC Strategic Plan Implementation Progress Reporting by MCC members Reporting of colorectal cancer screening rates by appropriate organizations

More Related